He saw the problems of conventional visual field testing with large, bulky machines – these were unpleasant to use, expensive, broke down and were a bottleneck to flow for already crowded glaucoma clinics world-wide. He saw the incredible benefit of an online application which could provide visual field testing on any computer or tablet, reducing the cost, improving the access and use-experience of visual field testing, and allowing proper digital integration with modern electronic medical records and telemedicine systems.
A/Prof Skalicky began researching the mathematics behind visual field testing algorithms and piece by piece, night after night, carefully put together the code required to test peripheral vision. He thought carefully about re-engineering the features of visual field testing so that it would work on any computer, and built the test accordingly. He deployed it on a simple webpage and began collecting validation data from patients – first from those with normal vision to establish a normative cohort, and then those with visual field loss from glaucoma to validate the product.
One patient, who was a senior programmer, cloud architect and AI engineer at Microsoft, saw the amazing translational potential of the technology and wanted to help. He linked A/Prof Skalicky with Microsoft, through the Microsoft for Startups program, and leveraged the huge expertise of the global Microsoft network to ensure optimal global deployment and cybersecurity. He helped A/Prof Skalicky build the Artificial Intelligence models required for the patient monitoring required for the test.
As the application grew in sophistication and complexity, A/Prof Skalicky asked Alex Verrico, expert programmer who already had significant industry experience, to take the role of Chief Technical Officer. Working together Alex and Simon have continued to refine and build a sophisticated application of global standards.
In the meantime work continued to scientifically validate the application, leading to several high caliber prizes at international conferences and prestigious publications. The team prepared a submission for Australian Government Therapeutics Goods Administration approval and achieved approval in the UK and many countries in Africa.
They have reached out to researchers eager to collaborate from UK, Vietnam, Israel, Brazil, Uganda, South Africa and New Zealand. A/Prof Skalicky has travelled to conferences in Europe, USA, Australasia and Africa meeting enthusiastic support for Eyeonic.
© Eyeonic | Website by en&co